To date, the diagnostic yield (i.e., the proportion of patients in whom the testing technique yields a definitive diagnosis) of BC PIK3CA mutation testing has been challenging to measure, given the variability in prevalence of PIK3CA mutations throughout BC subtypes and lack of guidelines for testing in clinical practice [20]. Here, PIK3CA is linked to breast cancer.